Methohexitalduring pregnancy and lactation, Methohexitalcategory by FDA, its use during pregnancy and lactation its teratogenic effects are described.
Small amount of drug excrete into breast milk, if required low dose should be prescribed.
| Methohexital during pregnancy and lactation | |
| Pregnancy | Category B ( by FDA ) |
| | Methohexital drug crosses the placenta no animal studies revealed teratogenic effects, not much adequate controlled studies, use with caution |
| Breast feeding | Methohexital excreted into breast milk, use with caution. |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.